Similar articles for PMID: 31635683

Year	Number of Results
2000	1
2001	1
2006	2
2007	2
2008	4
2009	2
2010	3
2011	2
2012	3
2013	3
2014	5
2015	7
2016	13
2017	16
2018	13
2019	12
2020	4
2021	1
2024	0

1

Synthesis and Evaluation of a Novel Small-molecule Compound as an Anticancer Inhibitor of CD147.

Fu ZG, Wang Y, Wang S, Shao D, Tian L, Li YX, Jiang JL, Chen ZN, Wen N. Fu ZG, et al. Biomed Environ Sci. 2019 Sep;32(9):673-686. doi: 10.3967/bes2019.086. Biomed Environ Sci. 2019. PMID: 31635683 Free article.

2

The small-molecule compound AC-73 targeting CD147 inhibits leukemic cell proliferation, induces autophagy and increases the chemotherapeutic sensitivity of acute myeloid leukemia cells.

Spinello I, Saulle E, Quaranta MT, Pasquini L, Pelosi E, Castelli G, Ottone T, Voso MT, Testa U, Labbaye C. Spinello I, et al. Haematologica. 2019 May;104(5):973-985. doi: 10.3324/haematol.2018.199661. Epub 2018 Nov 22. Haematologica. 2019. PMID: 30467201 Free PMC article.

3

A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells.

Fu ZG, Wang L, Cui HY, Peng JL, Wang SJ, Geng JJ, Liu JD, Feng F, Song F, Li L, Zhu P, Jiang JL, Chen ZN. Fu ZG, et al. Oncotarget. 2016 Feb 23;7(8):9429-47. doi: 10.18632/oncotarget.6990. Oncotarget. 2016. PMID: 26882566 Free PMC article.

4

Repressing CD147 is a novel therapeutic strategy for malignant melanoma.

Hu X, Su J, Zhou Y, Xie X, Peng C, Yuan Z, Chen X. Hu X, et al. Oncotarget. 2017 Apr 11;8(15):25806-25813. doi: 10.18632/oncotarget.15709. Oncotarget. 2017. PMID: 28445958 Free PMC article. Review.

5

CD147 knockdown improves the antitumor efficacy of trastuzumab in HER2-positive breast cancer cells.

Xiong L, Ding L, Ning H, Wu C, Fu K, Wang Y, Zhang Y, Liu Y, Zhou L. Xiong L, et al. Oncotarget. 2016 Sep 6;7(36):57737-57751. doi: 10.18632/oncotarget.10252. Oncotarget. 2016. PMID: 27363028 Free PMC article.

6

Knockout of CD147 inhibits the proliferation, invasion, and drug resistance of human oral cancer CAL27 cells in Vitro and in Vivo.

Pan S, Su Y, Sun B, Hao R, Gao X, Han B. Pan S, et al. Int J Biol Macromol. 2021 Jun 30;181:378-389. doi: 10.1016/j.ijbiomac.2021.03.102. Epub 2021 Mar 23. Int J Biol Macromol. 2021. PMID: 33766595

7

Hepatitis B X-interacting protein promotes cisplatin resistance and regulates CD147 via Sp1 in ovarian cancer.

Zou W, Ma X, Yang H, Hua W, Chen B, Cai G. Zou W, et al. Exp Biol Med (Maywood). 2017 Mar;242(5):497-504. doi: 10.1177/1535370216685007. Epub 2017 Jan 5. Exp Biol Med (Maywood). 2017. PMID: 28056551 Free PMC article.

8

Dual effects of an anti-CD147 antibody for Esophageal cancer therapy.

Wang M, Zhang S, Sun Q, Yang X, Wang Y, Shang R, Zhu Y, Yao H, Li Y. Wang M, et al. Cancer Biol Ther. 2019;20(12):1443-1452. doi: 10.1080/15384047.2019.1647052. Epub 2019 Aug 14. Cancer Biol Ther. 2019. PMID: 31411555 Free PMC article.

9

Targeted degradation of CD147 proteins in melanoma.

Zhou Z, Long J, Wang Y, Li Y, Zhang X, Tang L, Chang Q, Chen Z, Hu G, Hu S, Li Q, Peng C, Chen X. Zhou Z, et al. Bioorg Chem. 2020 Dec;105:104453. doi: 10.1016/j.bioorg.2020.104453. Epub 2020 Nov 4. Bioorg Chem. 2020. PMID: 33197849

10

Discovery and Biological Evaluation of CD147 N-Glycan Inhibitors: A New Direction in the Treatment of Tumor Metastasis.

Li W, Wang D, Ge Y, Zhang L, Wu J, Liu D. Li W, et al. Molecules. 2020 Dec 23;26(1):33. doi: 10.3390/molecules26010033. Molecules. 2020. PMID: 33374805 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

80 results

Results by year